These findings suggest no very clear proof harm or benefit with 4F-PCC for sufferers with aspect Xa inhibitorCassociated ICH
These findings suggest no very clear proof harm or benefit with 4F-PCC for sufferers with aspect Xa inhibitorCassociated ICH. Funding Statement This scholarly study was supported by departmental funds through…